Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morganroth

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
Chest|January 1, 1982
Embolized disc from a Beall mitral valve prosthesis. Real-time echocardiographic identificationC C Chen, J Morganroth, F J Pauletto
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety GroupP Jaillon, J Morganroth, I Brumpt, et al.
Cardiology Clinics|May 1, 1984
Ventricular arrhythmias. Clinical recognition and managementP F Nestico, N L DePace, J Morganroth
Annals of Internal Medicine|February 1, 1975
Type III hyperlipoproteinemia: an analysis of two contemporary definitionsD S Fredrickson, J Morganroth, R I Levy
Annals of Internal Medicine|February 1, 1975
The biochemical, clinical, and genetic features of type III hyperlipoproteinemiaJ Morganroth, R I Levy, D S Fredrickson
Clinical Pharmacology and Therapeutics|December 17, 2009
Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval)J Morganroth, R R Shah, J W Scott
Cardiovascular Clinics|January 1, 1992
Signal-averaged electrocardiography and ambulatory monitoringR Greenberg, J Morganroth, S Zelenkofske, et al.
Annals of Internal Medicine|September 1, 1976
Cholestyramine: an effective, twice-daily dosage regimenC B Blum, R J Havlik, J Morganroth
Clinical Cardiology|July 1, 1981
Large Mobile pedunculated left ventricular thrombus: identification by two-dimensional echocardiographyC C Chen, G W Webster, J Morganroth
Nature|July 11, 1970
SV40 virus-induced tumour specific transplantation antigen in cultured mouse cellsR W Smith, J Morganroth, P T Mora
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
Chest|January 1, 1982
Embolized disc from a Beall mitral valve prosthesis. Real-time echocardiographic identificationC C Chen, J Morganroth, F J Pauletto
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety GroupP Jaillon, J Morganroth, I Brumpt, et al.
Cardiology Clinics|May 1, 1984
Ventricular arrhythmias. Clinical recognition and managementP F Nestico, N L DePace, J Morganroth
Annals of Internal Medicine|February 1, 1975
Type III hyperlipoproteinemia: an analysis of two contemporary definitionsD S Fredrickson, J Morganroth, R I Levy
Annals of Internal Medicine|February 1, 1975
The biochemical, clinical, and genetic features of type III hyperlipoproteinemiaJ Morganroth, R I Levy, D S Fredrickson
Clinical Pharmacology and Therapeutics|December 17, 2009
Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval)J Morganroth, R R Shah, J W Scott
Cardiovascular Clinics|January 1, 1992
Signal-averaged electrocardiography and ambulatory monitoringR Greenberg, J Morganroth, S Zelenkofske, et al.
Annals of Internal Medicine|September 1, 1976
Cholestyramine: an effective, twice-daily dosage regimenC B Blum, R J Havlik, J Morganroth
Clinical Cardiology|July 1, 1981
Large Mobile pedunculated left ventricular thrombus: identification by two-dimensional echocardiographyC C Chen, G W Webster, J Morganroth
Nature|July 11, 1970
SV40 virus-induced tumour specific transplantation antigen in cultured mouse cellsR W Smith, J Morganroth, P T Mora
Pageof 22